CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing prevalence of cataract
3.4.1.2. Rise in adoption of premium intraocular lens
3.4.1.3. Increasing government initiatives
3.4.1.4. Increasing pool of geriatric population susceptible to ocular conditions
3.4.1.5. Growing number of diabetic patients

3.4.2. Restraints

3.4.2.1. Post-operative complications
3.4.2.2. Lack of coverage of premium lens

3.4.3. Opportunity

3.4.3.1. Availability of advanced technologies
3.4.3.2. Emerging nations

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS
3.7. CLINICAL TRIALS

CHAPTER 4 GLOBAL INTRAOCULAR LENS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MONOFOCAL IOLS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREMIUM IOLS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Toric intraocular lenses
4.3.3.2. Market size and forecast
4.3.3.3. Multifocal intraocular lenses
4.3.3.4. Market size and forecast
4.3.3.5. Accommodating intraocular lenses
4.3.3.6. Market size and forecast
4.3.3.7. Other IOLs
4.3.3.8. Market size and forecast

4.3.3.8.1. Blue light filtering IOLs
4.3.3.8.2. Market size and forecast
4.3.3.8.3. Phakic IOLs
4.3.3.8.4. Market size and forecast
4.3.3.8.5. Aspheric IOLs
4.3.3.8.6. Market size and forecast

CHAPTER 5 GLOBAL INTRAOCULAR LENSES MARKET BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS (ASCS)

5.3.1. Market size and forecast

5.4. OPTHALMOLOGY CLINICS

5.4.1. Market size and forecast

5.5. EYE RESEARCH INSTITUTES

5.5.1. Market size and forecast

CHAPTER 6 GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. POLYMETHYLMETHACRYLATE (PMMA)

6.2.1. Market size and forecast

6.3. SILICONE

6.3.1. Market size and forecast

6.4. HYDROPHOBIC ACRYLIC

6.4.1. Market size and forecast

CHAPTER 7 GLOBAL INTRAOCULAR LENS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Netherlands market size and forecast
7.3.10. Norway market size and forecast
7.3.11. Russia market size and forecast
7.3.12. Sweden market size and forecast
7.3.13. Switzerland market size and forecast
7.3.14. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. New Zealand market size and forecast
7.4.10. Taiwan market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Saudi Arabia market size and forecast
7.5.6. South Africa market size and forecast
7.5.7. Chile market size and forecast
7.5.8. Columbia market size and forecast
7.5.9. Egypt market size and forecast
7.5.10. Iran market size and forecast
7.5.11. Israel market size and forecast
7.5.12. Turkey market size and forecast
7.5.13. Venezuela market size and forecast
7.5.14. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ALCON (A NOVARTIS AG DIVISION)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.1.6. Strategy share (%)

8.2. CARL ZEISS MEDITEC AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.2.6. Strategy share (%)

8.3. EYEKON MEDICAL, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.3.6. Strategy share (%)

8.4. HUMANOPTICS AG

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.4.6. Strategy share (%)

8.5. HOYA GROUP

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.5.6. Strategy share (%)

8.6. JOHNSON & JOHNSON

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.6.6. Strategy share (%)

8.7. LENSTEC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.7.6. Strategy share (%)

8.8. RAYNER

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.8.6. Strategy share (%)

8.9. STAAR SURGICAL

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.9.6. Strategy share (%)

8.10. VALEANT

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
8.10.6. Strategy share (%)